Drug Cos. Urge 3rd Circ. To Rethink Eye Drop Suit Ruling
Pfizer, Merck & Co. and other drug companies told the Third Circuit on Wednesday that its decision last month to revive a putative class action accusing them of boosting eye drop...To view the full article, register now.
Already a subscriber? Click here to view full article